Table 3. Baseline clinical characteristics of study patients based on the presence of visceral obesity.
| Parameter | Patients with visceral obesity, n = 54 |
Patients without visceral obesity, n = 30 |
p |
|---|---|---|---|
| Mean age (range), years | 58.5 (53; 63) | 56 (51.5;63.5) | 0.71 |
| Male gender, n (%) | 45 (83.3) | 20 (66.7) | 0.613 |
| Mean BMI (range), kg/m2 | 28.7 (17.1;39.1) | 25.9 (18.3;38.4) | 0.005 |
| Characteristic adipose tissue distribution | |||
| Abdominal fat area, cm2 | 541 (381;725) | 357 (253;623) | 0.00 |
| VAT area (range), cm2 | 197(145;301) | 108 (64;124) | 0.00 |
| SAT area (range), cm2 | 316 (201;501) | 253 (159;498) | 0.00 |
| VAT/SAT | 0.62 (0.60;0.72) | 0.43 (0.24;0.50) | 0.00 |
| Risk Factors | |||
| Documented arterial hypertension, n (%) | 54 (100.0) | 29 (96.7) | 0.207 |
| Smoking, n (%) | 33 (61.1) | 12 (40.0) | 0.109 |
| Hypercholesterolemia, n (%) | 43 (79.6) | 20 (66.7) | 0.25 |
| Prior myocardial infarction, n (%) | 11 (20.4) | 6 (20.0) | 0.21 |
| Stroke | 5 (9.3) | 2 (6.7) | 0.14 |
| Atrial fibrillation | 2 (3.7) | 1 (3.3) | 0.169 |
| Angina | 45 (83.3) | 22 (73.3) | 0.23 |
| Percutaneous coronary intervention | 11(20.4) | 6 (20.0) | 0.12 |
| Coronary artery bypass surgery | 2 (3.7) | - | |
| CHF | |||
| CHF I CHF IIA-B CHF III |
14 (25.9) 6 (11.1) - |
9 (30.0) 4 (13.3) - |
0.17 0.74 - |
BMI–Body mass index; SAT–subcutaneous adipose tissue; VAT–visceral adipose tissue; CHF–congestive heart failure.